P Kohlberger Selected Research

Valacyclovir (Valtrex)

5/2002

Adenovirus-mediated thymidine kinase gene therapy for recurrent ovarian cancer: expression of coxsackie-adenovirus receptor and integrins alphavbeta3 and alphavbeta5.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

P Kohlberger Research Topics

Disease

5	Neoplasms (Cancer) 02/2004 - 05/2000
3	Ovarian Neoplasms (Ovarian Cancer) 02/2004 - 01/2002
1	Carcinoma in Situ 06/2003
1	Uterine Cervical Dysplasia 06/2003
1	Herpes Simplex 01/2002
1	Ovarian Epithelial Carcinoma 01/2002
1	Neoplasm Micrometastasis 01/2001
1	Lymphatic Metastasis 01/2001
1	Breast Neoplasms (Breast Cancer) 01/2001
1	Teratoma (Teratoid Tumor) 05/2000

Drug/Important Bio-Agent (IBA)

2	Thymidine KinaseIBA 05/2002 - 01/2002
2	Topotecan (Hycamtin)FDA LinkGeneric 05/2002 - 01/2002
1	Aspartic Acid ProteasesIBA 02/2004
1	Cathepsin DIBA 02/2004
1	KalininIBA 06/2003
1	integrin alphaVbeta5IBA 05/2002
1	Valacyclovir (Valtrex)FDA LinkGeneric 05/2002
1	Acyclovir (Aciclovir)FDA LinkGeneric 05/2002
1	IntegrinsIBA 05/2002
1	Integrin alphaVbeta3IBA 05/2002
1	Coxsackie and Adenovirus Receptor-Like Membrane ProteinIBA 05/2002
1	DNA (Deoxyribonucleic Acid)IBA 01/2002
1	ProdrugsIBA 01/2002
1	Hematoxylin (Haematoxylon)IBA 01/2001
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2001

Therapy/Procedure

1	Therapeutics 05/2000
1	Splints (Splint) 05/2000